> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Review Period Set for Supera Stent System
- URL: https://www.fdaweb.com/review-period-set-for-supera-stent-system/
- Published: 2016-02-22T12:00:00.000Z
- Updated: 2026-09-15T02:37:47.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134850

*Federal Register* Notice: FDA has determined the regulatory review period for IDEV Technologies’ Supera Peripheral Stent System is 1,894 days for extending a patent which claims the medical device. The system is indicated to improve luminal diameter in treating patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery and/or popliteal artery with reference vessel diameters of 4.0 to 6.5 millimeters (mm) and lesion lengths up to 140 mm. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-02-22/pdf/2016-03542.pdf?ref=fdaweb.com)